Cellebrite DI Ltd. (CLBT) Institutional Holdings & 13F Data (Q2 2026)

CLBT ranks #2968 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CLBT is a top-conviction position for Axon Enterprise, Inc. — at 100.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CLBT belongs to True Wind Capital Management, L.P., but the position matters far more to Axon Enterprise, Inc., who has 100.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Phoenix Financial Ltd. has added to its CLBT position for two straight quarters, increasing it by $45.0M to reach $90.2M today.

T. Rowe Price has trimmed its CLBT position for two straight quarters, cutting it by $118.8M while still holding $34.8M.

CLBT is down 1.9% today, but institutions show net buying of $151.2M this quarter — a divergence between today's price move and the underlying institutional flow.

CLBT closed its latest fiscal year with net income of $78.3M, and currently trades at a P/E of 37.1.

• Profitable — net income of $78.3M in the latest fiscal year
• Revenue grew 18.6% year over year
• Net income improved year over year, from -$283.0M to $78.3M
• Generated $173.5M in positive operating cash flow
• Current ratio of 1.56x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.94x equity — within a conventional range